Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02929576
Title Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer (ENDEAR)
Acronym ENDEAR
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements No
Sponsors Medivation, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.